window-to-japan.eu

Window to Japan

Otsuka Pharma obtains registration in Japan for new pro patch”, for percutaneous application of a dopamine receptor agonist “

Posted in News By schmid_wordpressPosted on

Indications are Parkinson’s disease and idiopathic restless legs syndrome

Otsuka Pharma press release, Dec. 25, 2012

Otsuka Pharma obtains registration in Japan for new pro patch”, for percutaneous application of a dopamine receptor agonist “
Scroll to top